Correlation Between Pulmonx Corp and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pulmonx Corp and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmonx Corp and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmonx Corp and Bone Biologics Corp, you can compare the effects of market volatilities on Pulmonx Corp and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmonx Corp with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmonx Corp and Bone Biologics.

Diversification Opportunities for Pulmonx Corp and Bone Biologics

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Pulmonx and Bone is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pulmonx Corp and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Pulmonx Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmonx Corp are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Pulmonx Corp i.e., Pulmonx Corp and Bone Biologics go up and down completely randomly.

Pair Corralation between Pulmonx Corp and Bone Biologics

Given the investment horizon of 90 days Pulmonx Corp is expected to generate 0.52 times more return on investment than Bone Biologics. However, Pulmonx Corp is 1.92 times less risky than Bone Biologics. It trades about -0.09 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.11 per unit of risk. If you would invest  829.00  in Pulmonx Corp on August 28, 2024 and sell it today you would lose (168.00) from holding Pulmonx Corp or give up 20.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pulmonx Corp  vs.  Bone Biologics Corp

 Performance 
       Timeline  
Pulmonx Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pulmonx Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Pulmonx Corp is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Pulmonx Corp and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pulmonx Corp and Bone Biologics

The main advantage of trading using opposite Pulmonx Corp and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmonx Corp position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind Pulmonx Corp and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance